Send to

Choose Destination
J Surg Orthop Adv. Fall 2018;27(3):226-230.

Early-Stage Chronic Kidney Disease and Hip Fracture Mortality.

Author information

Ascension Crittenton Hospital, Rochester, Michigan.
Department of Orthopaedic Surgery, Henry Ford Health System, Detroit, Michigan.
Department of Orthopaedic Surgery, Henry Ford Health System, Detroit, Michigan; e-mail:
Department of Orthopaedic Surgery, University of Rochester Medical Center, Rochester, New York.


Chronic kidney disease (CKD) is a documented risk factor for hip fracture mortality. CKD represents a spectrum of disease and there is no clear evidence differentiating the risk between patients with early versus end-stage CKD. The purpose of this study was to explore the relationship between the stages of CKD and mortality following operative treatment of hip fractures. Four hundred ninety-eight patients were analyzed; 81 were identified as having CKD. This study followed overall patient mortality at 90 days and at 1 year postoperatively. Patients with CKD had higher mortality at both 90 days and 1 year compared with those without CKD (hazard ratio 1.69 and 1.84, respectively). In a subgroup analysis to determine the effect of CKD stage, only stage 3 CKD was associated with increased mortality. The orthopaedic surgeon can play a key role in identifying at-risk patients and help to facilitate additional management. (Journal of Surgical Orthopaedic Advances 27(3):226-230, 2018).


Supplemental Content

Full text links

Icon for Data Trace Publishing Company
Loading ...
Support Center